Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib

China Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib, Find details about China Lapatinib, Pharmaceutical Intermediate Lapatinib from Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib

Model NO.
D-sung Lapatinib
Product Name
Lapatinib
Name
Lapatinib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Antineoplastic;Anti-Cancer
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
231277-92-2
Mf
C29h26clfn4o4s
MW
581.057543
Melting Point
136-140°c
Density
1.381
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Lapatinib
Product Name
Lapatinib
Name
Lapatinib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Antineoplastic;Anti-Cancer
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
231277-92-2
Mf
C29h26clfn4o4s
MW
581.057543
Melting Point
136-140°c
Density
1.381
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib
Pharmaceutical Intermediate Purity Lapatinib Antineoplastic LapatinibPowder Raw Powder Lapatinib
Product Description
Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder LapatinibPharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib
Product Details
Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib
Product nameLapatinib
Cas number231277-92-2
AppearanceWhite powder
MFC29H26ClFN4O4S
MW581.057543

Lapatinib ditosylate is approved to be used with other drugs to treat: Breast cancer that is advanced or has metastasized (spread to other parts of the body).

It is used with:Capecitabine in women with HER2 positive (HER2+) breast cancer whose disease has not gotten better with other chemotherapy.Letrozole in postmenopausal women with HER2+ and hormone receptor positive breast cancer who need hormone therapy.Lapatinib ditosylate is also being studied in the treatment of other types of cancer.

Application&Function

Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib

In the experiment of Chinese hamster, no carcinogenic effect was found, and no genetic toxicity was found. There was no effect on mating ability and fertility of rats under high dose. There are 1 cases reported in pregnant women in March before taking lapatinib, full-term pregnancy after the birth of healthy children .
Lapatinib in Indonesia and capecitabine combination in the treatment of breast cancer, the effect is better, and of anthracene ring antibiotics, taxanes and trastuzumab resistant patients effective, mild side effects, for advanced or metastatic breast cancer patients and a drug treatment.

Specification

Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder LapatinibPharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder LapatinibPharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib
Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder LapatinibPharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder LapatinibPharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib
Pharmaceutical Intermediate Purity Lapatinib Antineoplastic Lapatinibpowder Raw Powder Lapatinib